Science · 1981 · 39 citations · 20 references
MedicinePharmacologyPharmacotherapyNeuropharmacologyPsychopharmacologySubstance Use DisordersDevelopmental PharmacologyNeonatal PharmacologyOpioid PharmacologyPerinatal PharmacologyPerinatal PsychopharmacologyReproductive PharmacologyMethadone Maintenance TherapyMethadone Maintenance TreatmentNaloxone Adverse EffectsNeonatal Opioid Withdrawal TreatmentOpioid Effects On The FetusPrenatal NeuropharmacologyReproductive Drug Pharmacology
Long-term oral administration of the long-acting opiate 1-alpha-acetylmethadol (LAAM) to female rats beginning on the day of conception interfered with the dams' ability to carry litters to term. When treatment was initiated 3 weeks prior to mating this effect was not observed. Daily administration of the opiate antagonist naloxone from day 14 of gestation through term, to precipitate withdrawal in utero, resulted in increased stillbirths, decreased pup weight and size, and weight loss 24 hours after birth. These data question the validity of animal experiments which purport to be models for methadone maintenance programs but in which treatment is started immediately prior to or soon after conception. They also suggest that withdrawal in utero may be responsible for many of the adverse effects of opiates on human and animal development.
20
Carl Zelson, Sook Ja Lee, Marie B. Casalino · New England Journal of Medicine · 1973 · 167 citations
Medicine, Child Health, Pediatrics +12
Perinatal addiction: Outcome and management
James F. Connaughton, Dian S Reeser, Jacob Schut et al. · American Journal of Obstetrics and Gynecology · 1977 · 154 citations
Methadone and l-Methadyl Acetate
Jerome H. Jaffe · JAMA · 1971 · 119 citations